- Home
- AXS vs RVMD Comparison
AXS vs RVMD Comparison
Compare AXS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXS
- RVMD
- Stock Information
- Founded
- AXS 2001
- RVMD 2014
- Country
- AXS Bermuda
- RVMD United States
- Employees
- AXS N/A
- RVMD N/A
- Industry
- AXS Property-Casualty Insurers
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXS Finance
- RVMD Health Care
- Exchange
- AXS Nasdaq
- RVMD Nasdaq
- Market Cap
- AXS 8.2B
- RVMD 7.5B
- IPO Year
- AXS N/A
- RVMD 2020
- Fundamental
- Price
- AXS $98.20
- RVMD $38.58
- Analyst Decision
- AXS Strong Buy
- RVMD Strong Buy
- Analyst Count
- AXS 9
- RVMD 12
- Target Price
- AXS $107.75
- RVMD $68.67
- AVG Volume (30 Days)
- AXS 750.5K
- RVMD 3.1M
- Earning Date
- AXS 07-29-2025
- RVMD 08-06-2025
- Dividend Yield
- AXS 1.79%
- RVMD N/A
- EPS Growth
- AXS 54.31
- RVMD N/A
- EPS
- AXS 10.08
- RVMD N/A
- Revenue
- AXS $6,055,200,000.00
- RVMD N/A
- Revenue This Year
- AXS $2.46
- RVMD N/A
- Revenue Next Year
- AXS $10.37
- RVMD $241.39
- P/E Ratio
- AXS $9.78
- RVMD N/A
- Revenue Growth
- AXS 5.79
- RVMD N/A
- 52 Week Low
- AXS $69.44
- RVMD $29.17
- 52 Week High
- AXS $107.19
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- AXS 41.18
- RVMD 42.66
- Support Level
- AXS $97.36
- RVMD $36.37
- Resistance Level
- AXS $100.00
- RVMD $38.03
- Average True Range (ATR)
- AXS 1.88
- RVMD 1.47
- MACD
- AXS -0.63
- RVMD -0.23
- Stochastic Oscillator
- AXS 15.53
- RVMD 18.71
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.